Form 4: Hartford Insurance Group Executive Vice President Lori A. Rodden Reports Stock Option Grant
SEC Form 4
Executive Vice President Lori A. Rodden of Hartford Insurance Group reports the acquisition of stock options and direct ownership of common stock.
Summary
- Lori A. Rodden, an Executive Vice President at Hartford Insurance Group, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- The report indicates that Rodden acquired 9,467 stock options with an exercise price of $116.41 on February 25, 2025, which will vest in three equal installments over the next three years.
- Rodden directly owns 18,399.962 shares of Hartford Insurance Group common stock.
- She also holds several other stock option grants with varying exercise prices and vesting schedules.
Sentiment
Score: 5
Explanation: This is a routine filing, indicating standard executive compensation practices. It doesn't inherently suggest positive or negative sentiment.
Positives
- The acquisition of stock options aligns the executive's interests with those of the shareholders.
- The vesting schedule of the new options incentivizes long-term performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders.
Stakeholder Impact
- The stock option grant could be viewed positively by shareholders as it aligns management's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 02/23/2021 | Grant date of stock options with exercise price $51.87. |
| 02/25/2022 | Grant date of stock options with exercise price $55.27. |
| 02/23/2023 | Grant date of stock options with exercise price $69.41. |
| 02/28/2023 | Grant date of stock options with exercise price $78.28. |
| 02/27/2024 | Grant date of stock options with exercise price $95.74. |
| 02/23/2024 | Stock options with exercise price $51.87 became fully exercisable. |
| 02/25/2023 | Stock options with exercise price $55.27 became fully exercisable. |
| 02/28/2024 | One-third of the options with exercise price $78.28 became exercisable. |
| 02/23/2025 | Stock options with exercise price $69.41 became fully exercisable. |
| 02/27/2025 | One-third of the options with exercise price $95.74 became exercisable. |
| 02/25/2025 | Date of the reported transaction and grant of new stock options with exercise price $116.41. |
| 02/28/2025 | An additional one-third of the options with exercise price $78.28 will become exercisable. |
| 02/25/2026 | One-third of the options with exercise price $116.41 will become exercisable. |
| 02/27/2026 | An additional one-third of the options with exercise price $95.74 will become exercisable. |
| 02/28/2026 | The remaining one-third of the options with exercise price $78.28 will become exercisable. |
| 02/25/2027 | An additional one-third of the options with exercise price $116.41 will become exercisable. |
| 02/27/2027 | The remaining one-third of the options with exercise price $95.74 will become exercisable. |
| 02/25/2028 | The remaining one-third of the options with exercise price $116.41 will become exercisable. |
| 02/23/2031 | Expiration date of stock options with exercise price $51.87. |
| 02/25/2030 | Expiration date of stock options with exercise price $55.27. |
| 02/23/2032 | Expiration date of stock options with exercise price $69.41. |
| 02/28/2033 | Expiration date of stock options with exercise price $78.28. |
| 02/27/2034 | Expiration date of stock options with exercise price $95.74. |
| 02/25/2035 | Expiration date of stock options with exercise price $116.41. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.